Bluejay Diagnostics (BJDX) Net Margin (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed Net Margin for 2 consecutive years, with 5415.13% as the latest value for Q3 2023.
- Quarterly Net Margin changed N/A to 5415.13% in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 3767.58% through Dec 2023, down 70149.0% year-over-year, with the annual reading at 816267.34% for FY2025, 81372298.0% up from the prior year.
- Net Margin hit 5415.13% in Q3 2023 for Bluejay Diagnostics, down from 3200.75% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 797.35% in Q2 2022 to a low of 5415.13% in Q3 2023.